D. E. Shaw & Co., Inc. Repligen Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $69,390 - $88,255	500 Added 5.0%	10,500 $1.67 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $110,735 - $144,248	-800 Reduced 7.41%	10,000 $1.41 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $246,816 - $316,960	-1,600 Reduced 12.9%	10,800 $1.82 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $1.3 Million - $1.76 Million	-8,000 Reduced 39.22%	12,400 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $1.78 Million - $2.84 Million	11,100 Added 119.35%	20,400 $3.82 Million
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $675,264 - $902,496	-4,800 Reduced 34.04%	9,300 $1.51 Million
Q1 2022 May 16, 2022	SELL	$161.19 - $257.96 $1.53 Million - $2.45 Million	-9,500 Reduced 40.25%	14,100 $2.65 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $2.6 Million - $3.2 Million	10,500 Added 80.15%	23,600 $6.25 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $2.55 Million - $4.25 Million	13,100 New	13,100 $3.79 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $1.66 Million - $2.21 Million	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $2.43 Million - $3.05 Million	-13,500 Reduced 57.45%	10,000 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $1.8 Million - $2.24 Million	23,500 New	23,500 $1.8 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.